Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells

被引:399
|
作者
Burger, JA
Burger, M
Kipps, TJ
机构
[1] Univ Calif San Diego, Sch Med, Div Hematol Oncol, Dept Med, La Jolla, CA 92093 USA
[2] Scripps Res Inst, Dept Immunol, La Jolla, CA USA
关键词
D O I
10.1182/blood.V94.11.3658.423k11_3658_3667
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemokines play a central role for lymphocyte trafficking and homing. The mechanisms that direct the tissue localization of B cells from patients with chronic lymphocytic leukemia (B-CLL) are unknown. We found that CLL B cells express functional CXCR4 receptors for the chemokine stromal cell-derived factor-1 (SDF-1), as demonstrated by receptor endocytosis, calcium mobilization, and actin polymerization;ion assays. Moreover, CLL B cells displayed chemotaxis to this chemokine that could be inhibited by monoclonal antibodies (MoAbs) against CXCR4, pertussis toxin. or Wortmannin, a phosphatidylinositol 3-kinase inhibitor. That this chemotaxis may be involved in the homing of CLL cells is argued by studies in which CLL B cells were cocultured with a murine marrow stromal cell line that secretes SDF-1. Within 2 hours, CLL B cells spontaneously migrated beneath such stromal cells in vitro (pseudoemperipolesis). This migration could be inhibited by pretreatment of CLL B cells with anti-CXCR4 MoAbs, SDF-1 alpha, or pertussis-toxin. Furthermore, we noted strong downmodulation of CXCR4 on CLL B cells that migrated into the stromal cell layer. These findings demonstrate that the chemokine receptor CXCR4 on CLL B cells plays a critical role for heterotypic adherence to marrow stromal cells and provide a new mechanism to account for the marrow infiltration by neoplastic B cells. (C) 1999 by The American Society of Hematology.
引用
收藏
页码:3658 / 3667
页数:10
相关论文
共 50 条
  • [21] Cimigenol depresses acute myeloid leukemia cells protected by breaking bone marrow stromal cells via CXCR4/SDF-1a
    Ma, Bangyun
    Dai, Huibo
    Dai, Xingbin
    Qian, Shushu
    Sha, Xiaocao
    Sun, Xuemei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (02)
  • [22] Chemokine receptor CXCR4-dependent internalization and resecretion of functional chemokine SDF-1 by bone marrow endothelial and stromal cells
    Dar, A
    Goichberg, P
    Shinder, V
    Kalinkovich, A
    Kollet, O
    Netzer, N
    Margalit, R
    Zsak, M
    Nagler, A
    Hardan, I
    Resnick, I
    Rot, A
    Lapidot, T
    NATURE IMMUNOLOGY, 2005, 6 (10) : 1038 - 1046
  • [23] Marrow Stromal Cells Induce TCL1 Expression in Chronic Lymphocytic Leukemia B Cells
    Sivina, Mariela
    Hartmann, Elena
    Keating, Michael
    Wierda, William G.
    Rosenwald, Andreas
    Burger, Jan A.
    BLOOD, 2009, 114 (22) : 927 - 927
  • [24] Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells
    Burger, M
    Hartmann, T
    Krome, M
    Rawluk, J
    Tamamura, H
    Fujii, N
    Kipps, TJ
    Burger, JA
    BLOOD, 2005, 106 (05) : 1824 - 1830
  • [25] Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1
    Bajetto, A
    Bonavia, R
    Barbero, S
    Piccioli, P
    Costa, A
    Florio, T
    Schettini, G
    JOURNAL OF NEUROCHEMISTRY, 1999, 73 (06) : 2348 - 2357
  • [26] Down-regulation of CXCR4 chemokine receptor and impairment of migration in chronic lymphocytic cells treated by histone deacetylase inhibitors.
    Lagneaux, L
    Delforge, A
    Dejeneffe, M
    Massy, MT
    Mortier, C
    Meuleman, N
    Bron, D
    BLOOD, 2003, 102 (11) : 433A - 433A
  • [27] Targeting the autophagy in bone marrow stromal cells overcomes resistance to vorinostat in chronic lymphocytic leukemia
    Ding, Lu
    Zhang, Wan
    Yang, Lili
    Pelicano, Helene
    Zhou, Kaiwen
    Yin, Ran
    Huang, Ruibin
    Zeng, Junyi
    ONCOTARGETS AND THERAPY, 2018, 11 : 5151 - 5170
  • [28] Attenuation of CXCR4 Responses by CCL18 in Acute Lymphocytic Leukemia B Cells
    Catusse, J.
    Wollner, S.
    Leick, M.
    Schroettner, P.
    Schraufstaetter, I.
    Burger, M.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 225 (03) : 792 - 800
  • [29] CXCR4 chemokine receptor antagonists inhibit activation, migration, and survival of chronic lymphocytic leukemia B cells in response to stromal cell-derived factor-1 (SDF-1/CXCL12).
    Burger, M
    Hartmann, T
    Fujii, N
    Kipps, TJ
    Burger, JA
    BLOOD, 2003, 102 (11) : 435A - 435A
  • [30] The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells
    Stamatopoulos, Basile
    Meuleman, Nathalie
    De Bruyn, Cecile
    Delforge, Alain
    Bron, Dominique
    Lagneaux, Laurence
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1136 - 1143